Clinical Trials on Androgens

Total 147 results

Centre Hospitalier Universitaire, Amiens

Recruiting

Comparison Between Calculated Bioavailable Testosterone Level With Radio-immunoassay Result. (TESTOBIO)

Androgens | Testosterone

France
Bayer

Completed

Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)

Male | Androgens (Deficiency)

Italy, Spain, Austria, Finland, United Kingdom, Germany, Ireland, Sweden
University Hospital Inselspital, Berne
University of Zurich; University Hospital Muenster

Completed

Genetic Polymorphism of the Androgen Receptor-Gene and Sexual Function in Middle Aged Women (CAG-Libido)

Polymorphism, Genetic | Libido | Receptors, Androgen | Androgen Effect

Switzerland
St Vincent's Hospital, Sydney

Terminated

Activity of Seviteronel in Patients With Androgen Receptor (AR)-Positive Glioblastoma (START)

Solid Tumor | Androgen Receptor Gene Overexpression

Australia
Saliva Biomarkers, Inc.

Unknown

Comparison of Salivary and Serum Free Testosterone in Normal and Hypogonadal Men

Known Androgen Deficiency

United States
Aristotle University Of Thessaloniki

Completed

Androgen Receptor mRNA Expression is Positively Associated With Live Birth in Women Undergoing IVF Independently of the Type of Ovarian Response

Poor Ovarian Response | Androgen Receptor Gene Overexpression | Normal Responders | Bologna Criteria
GlaxoSmithKline

Completed

Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males

Healthy Subjects | Androgen Deficiency

United States
IVI Madrid

Completed

Effect of Resveratrol on Metabolic Parameters and Oocyte Quality in PCOS Patients (RES-IVF)

Inflammatory Markers | Androgen Profile | IVF Outcome

Spain
Merck Sharp & Dohme LLC

Completed

Effects of Andriol Testocaps in Symptomatic Late-Onset Hypogonadism (43203)

Hypogonadism | Androgens
Instituto Bernabeu

Not yet recruiting

TRAP Study: Testosterone for Androgen Receptor Polymorphism (TRAP)

Fertility Disorders

Spain
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI); Astellas Pharma US, Inc.

Active, not recruiting

Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers

Salivary Cancer

United States
Universitaire Ziekenhuizen KU Leuven

Completed

Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation

Hypogonadism | Estrogens | Androgens | Testosterone
MacroGenics

Recruiting

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint Molecule

United States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
The Netherlands Cancer Institute
Astellas Pharma Inc

Completed

Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation (DARANA)

Prostate Cancer | Androgen Receptor Abnormal | DNA
Veru Inc.

Terminated

Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent (VERACITY)

Metastatic Castration-resistant Prostate Cancer | Androgen Resistant Prostatic Cancer

United States
Brigham and Women's Hospital
National Institutes of Health (NIH)

Recruiting

Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)

Pain | Opioid Use | Androgen Deficiency

United States
UNICANCER

Completed

Study on Androgen Receptor and Triple Negative Breast Cancer (START)

Breast Cancer Female | Triple Negative and Androgen Receptor Positive

France
University of Nicosia

Not yet recruiting

The Effect of Androgen Receptor Polymorphism on Endometrial Cancer (AREC)

Endometrial Disorder | Androgen Receptor Abnormal
AstraZeneca

Completed

Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor

United Kingdom, United States
University of Catanzaro

Unknown

AR, IGF-IR, IR and Peripheral Artery Disease (ANIMALPAD)

Androgen Receptor Abnormal | Insulin-Like Growth Factor I Deficiency | Insulin Receptor, Defect in

Italy
Sidney Kimmel Comprehensive Cancer Center at Johns...

Recruiting

Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression

Prostate Cancer

United States
Pfizer
Astellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Advanced, Androgen Receptor Positive Triple Negative Breast Cancer

United States, Spain, Belgium, Canada, Ireland, United Kingdom, Italy
Applied Biology, Inc.
Hospital Universitario Ramon y Cajal

Withdrawn

In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity

COVID-19 | SARS-CoV 2 | COVID | Androgenetic Alopecia | Androgen Deficiency | Androgen Receptor Abnormal

Spain
Neon Hospital

Completed

Effects of External Testosteron Intake on the Choroid: Enhance-depth Imaging Optical Coherence Tomography Study

Effects of the External Testosteron Intake Over the Choroids of the Patients With Androgen Deficiency

Turkey
Galderma R&D

Completed

Minoxidil 2% Solution and Botanical Hair Regimen in Women With Thinning Hair and Female Pattern Hair Loss/Androgenic Alopecia

Female Pattern Hair Loss, Androgenic Alopecia

United States
Galderma R&D

Completed

Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia

Male Pattern of Hair Loss, Androgenic Alopecia

United States
Istituto Scientifico Romagnolo per lo Studio e...

Terminated

A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT) (ARTT)

Estrogen Receptor Positive Breast Cancer | Androgen Receptor Gene Overexpression | Progesterone Receptor Positive Tumor | Metastatic Breastcancer | Estrogen Receptor Negative Neoplasm | Progesterone Receptor Negative Neoplasm

Italy
HealthCore-NERI
Bayer; Besins Healthcare

Completed

Registry of Hypogonadism in Men (RHyMe)

Male Hypogonadism | Testosterone Deficiency | Androgen Deficiency

Italy, United Kingdom, Spain, Netherlands, Germany, Sweden
Jan Frystyk

Recruiting

Cross-sectional Study of 1200 Recreational Athletes With Former or Current Use of Androgenic Anabolic Steroids (FIDODK/BIC)

Heart Failure | Cardiovascular Morbidity | Androgen Deficiency

Denmark
University of California, Irvine
Applied Biology, Inc.

Withdrawn

COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression

Covid19 | Androgen Receptor Gene Overexpression

United States
Banaras Hindu University

Recruiting

of Androgen Receptor Expression in Breast Cancer With or Without BRCA Mutation

Breast Cancer

India
Dendreon

Completed

Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

Metastatic Androgen Independent Prostate Cancer

United States, Canada
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer

Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Metastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Androgen Receptor Positive

United States
Brown University
Cures Within Reach; Lifespan; Legorreta Cancer Center at Brown University

Recruiting

Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant (TASUC-Neo)

Urothelial Carcinoma Bladder | Androgen Receptor Positive

United States
Eunice Kennedy Shriver National Institute of Child...

Recruiting

Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity

Androgen Insensitivity Syndrome | Metabolic Parameters in AIS, CAIS, PAIS and MAIS | Tumor Formation in AIS, CAIS, PAIS and MAIS | Sexual Function AIS, CAIS, PAIS and MAIS

United States
Janssen Research & Development, LLC

Completed

A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)

Prostatic Neoplasms

United States, Canada
Universitaire Ziekenhuizen KU Leuven
Eli Lilly and Company; Kom Op Tegen Kanker; Teva Pharma

Recruiting

Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer (ABBICAR)

Triple Negative Breast Neoplasms

Belgium
University of Wisconsin, Madison
Madison Vaccines Incorporated

Completed

A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF

Prostate Cancer

United States
SCRI Development Innovations, LLC
Millennium Pharmaceuticals, Inc.

Completed

Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)

Metastatic Breast Cancer

United States
LTN PHARMACEUTICALS, INC.

Terminated

A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC (ARMOR3-SV)

Prostate Cancer

United States, France, Australia, Canada, Spain, United Kingdom, Italy, Belgium
Dana-Farber Cancer Institute
National Institute of Nursing Research (NINR)

Completed

A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer

Prostate Cancer

United States
Bavarian Nordic

Completed

A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer (BNIT-PR-001)

Androgen-insensitive Prostate Cancer

United States
US Oncology Research
Eli Lilly and Company; Oregon Health and Science University

Completed

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)

Androgen-independent Prostate Cancer

United States
Norwegian School of Sport Sciences
King's College London; Oslo University Hospital; Rigshospitalet, Denmark; University... and other collaborators

Terminated

Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose

Prostate Cancer | Resistance Exercise | Androgen Deprivation Therapy

Norway
Universitaire Ziekenhuizen KU Leuven

Unknown

Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy (ARNEO)

Prostate Cancer | Neoadjuvant Therapy | Prostatectomy | Androgen Antagonists

Belgium
Dana-Farber Cancer Institute
Massachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Oregon Health and Science University

Completed

The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer

Prostate Cancer | Metastatic, Androgen Independent Prostate Cancer

United States
Institut Mutualiste Montsouris
University of Turin, Italy

Recruiting

EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control. (ENHANCE)

Prostate Cancer | Androgen Deprivation Therapy

France
Herlev Hospital

Completed

Supervised Group Based Exercise for Men With Prostate Cancer on Androgen Deprivation Therapy

Prostatic Neoplasms | Androgen Deprivation Therapy | Exercise Therapy

Denmark
Follicum AB
Bioskin GmbH

Completed

To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin

Androgenic Alopecia

Germany
Venus Concept

Recruiting

Computer-Assisted Hair Restoration Study Using ARTAS System

Androgenic Alopecia

United States

Clinical Trials on Androgens

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Taiwan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations